Senior Business Development Manager

Contract type
Ongoing
Work mode
On-site · Ile-de-France, France
Experience
Senior · 5+ years

Job description

Senior Business Development Manager at Orakl Oncology responsible for building and running the partnership pipeline with pharma and biotech, from account targeting and prospecting to qualifying opportunities for the VP Business Development.

At a glance

Work mode
On-site · Ile-de-France, France
Languages
English – fluent, French

What you'll do

  • Identify and prioritise the pharma and biotech accounts where Orakl's offerings create the most value, based on their oncology pipelines and development stage
  • Tailor Orakl's value proposition to each account's programmes, priorities and decision makers
  • Engage decision makers at target accounts through direct outreach and introductions from Orakl's scientific, clinical and investor network
  • Assess every lead, inbound or outbound, and lead discovery meetings with VPs to understand their programmes, needs, decision process, budget and timing
  • Hand qualified opportunities to the VP BD
  • Keep pipeline data reliable so the team and leadership can forecast and decide from it
  • Track conversion by channel and by stage, and focus effort where it delivers results
  • Follow competitors, partnerships and deals in AI and patient-derived oncology models
  • Share market insights with internal teams and leadership to sharpen Orakl's positioning and priorities

What we're looking for

  • 5 to 8 years in business development, sales or account management, selling platforms, data or services to pharma and biotech
  • A record of building pipeline from scratch and converting first meetings into qualified opportunities
  • Scientific background (MSc or PhD in life sciences or a related field); comfortable discussing oncology, translational research and clinical development with scientists
  • Clear writer and confident presenter, at ease with senior scientists and executives
  • Hands-on and autonomous in a fast-moving startup
  • Fluent in English
  • Work on-site (offices in Ile-de-France) with occasional remote work, and regular travel to conferences and clients in Europe and the US

Nice to have

  • A network in pharma oncology or translational teams in Europe or the US
  • French

Your team

Business Development

The BD team, working closely with the VP BD, the Product Marketer, the scientific teams, the founders and the Communications & Events Lead.

Benefits

  • A central role in building Orakl's commercial engine, with the opportunity to grow with the BD team as Orakl scales
  • Direct exposure to pharma decision makers and to Orakl's founders
  • Join a fast pacing start up growing
  • Occasional remote work

How to get hired

  1. 1Hiring Manager Call: getting to know each other, aligning on expectations context
  2. 2Technical Deep Dive: detailed conversation about your experience and fit for the role, using examples of what you've done and how you like to work
  3. 3Case study: a take-home case to prepare and then to present in-person to the team
  4. 4Reference Call: with one or two former colleagues with whom you worked closely, including a direct manager
  5. 5Founder Interview: A final discussion with at least one founder on vision, culture fit, and mutual ambitions

Apply

Direct apply at Orakl Oncology

Opens the job posting at Orakl Oncology

About Orakl Oncology

Orakl bridges biological and artificial intelligence by building large cohorts of virtual cancer patients: real patients' tumors, paired with their medical history and deep biological data. Because they can test treatments on these virtual patients at scale, they can predict, with causal evidence, how a patient will respond to a drug long before it reaches the clinic, helping pharma companies bet on the right drugs, for the right patients, much earlier on.

Mission

Every cancer patient deserves a treatment that works for them.

Key facts

  • 2023
  • Oncology / biotech
  • Founded in 2023 by Fanny Jaulin, PhD, Diane-Laure Pagès and Gustave Ronteix, PhD
  • Spin-out from Gustave Roussy, one of Europe's leading cancer centers
  • Builds on 10 years of research
  • Backed by top international VCs and growing fast